Multiples aspects of VIH resistance to antiretroviral drugs.

被引:2
作者
Clevenbergh, P
Durant, J
Garraffo, R
Chaillou, S
Cua, E
Dellamonica, P
机构
[1] Hop Archet, Serv Malad Infect & Trop, F-06202 Nice 3, France
[2] Hop Louis Pasteur, Serv Pharmacol Clin, F-06002 Nice, France
[3] CHU Nice, Serv Med Interne, Nice, France
来源
MEDECINE ET MALADIES INFECTIEUSES | 2000年 / 30卷 / 09期
关键词
antiretroviral drugs kinetics; antiretroviral drugs resistance;
D O I
10.1016/S0399-077X(00)80022-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Despite the availability of an increasing number of antiretroviral drugs, many patients still fail to reach or maintain complete viral suppression. This is mainly due to the development of HIV drug resistance. In fact, viral replication is both a cause and a consequence of HIV drug resistance. Various factors have been involved in the appearance of resistance to antiretroviral drugs. These factors are related to the host, to drugs, to the physician, or to the virus. All these factors are at the same time causative agents or victims of HIV drug resistance. Various aspects of causes and consequence of drug resistance are discussed. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:551 / 564
页数:14
相关论文
共 120 条
[1]  
ACOSTA EP, 1999, MEDSCAPE HIV AIDS, P5
[2]   Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users [J].
Alexander, CS ;
Dong, W ;
Schechter, MT ;
O'Shaughnessy, MV ;
Strathdee, SA ;
Mo, T ;
Montaner, JSG ;
Harrigan, PR .
AIDS, 1999, 13 (08) :981-985
[3]  
ANGEL JB, 2000, C RETR OPP INF SAN F
[4]  
Aquaro S, 1998, J BIOL REG HOMEOS AG, V12, P23
[5]  
BACHELER LT, 1999, 36 ICAAC SEPT 26 29
[6]   TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-INFECTED CELLS WITH COMBINATIONS OF HIV-1-SPECIFIC INHIBITORS RESULTS IN A DIFFERENT RESISTANCE PATTERN THAN DOES TREATMENT WITH SINGLE-DRUG THERAPY [J].
BALZARINI, J ;
KARLSSON, A ;
PEREZPEREZ, MJ ;
CAMARASA, MJ ;
TARPLEY, WG ;
DECLERCQ, E .
JOURNAL OF VIROLOGY, 1993, 67 (09) :5353-5359
[7]  
BANGSBERG DR, 1999, 6 C RETR OPP INF FEB
[8]  
BAXTER JD, 1999, 6 C RETR OPP INF FEB
[9]   HIV-1 drug resistance in newly infected individuals [J].
Boden, D ;
Hurley, A ;
Zhang, LQ ;
Cao, YZ ;
Guo, Y ;
Jones, E ;
Tsay, J ;
Ip, J ;
Farthing, C ;
Limoli, K ;
Parkin, N ;
Markowitz, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (12) :1135-1141
[10]  
BRUNDAGE RC, 2000, 1 INT WORKSH CLIN PH